Roberts Pharmaceutical
Executive Summary
Company acquires 70,000 square foot distribution facility from Novartis. The facility, located in Buffalo Grove, Ill., will begin operations May 1 and will distribute Roberts' entire U.S. product line, including the orthostatic hypotension treatment, ProAmatine (midodrine), and the essential thrombocythemia treatment, Agrylin (anagrelide). Roberts purchased a manufacturing facility in Canada from Searle in July that is currently packaging OTC products. Prescription products will be phased in over the next year and a half, the company says...